Organ-specific Fibrosis Assays

About Innoprot

Innoprot is a privately held, revenue-generating Spanish CRO and product company serving the global biopharma research sector. Its core business model combines the sale of specialized research products (like primary cells and engineered cell lines) with fee-for-service contract research, particularly in cell line development and phenotypic/target-based assay services. The company's technology focuses on creating advanced cellular models for drug discovery in areas such as oncology, CNS disorders, fibrosis, and metabolic diseases, positioning it as a specialized tools and services provider in the pre-clinical research space.

Therapeutic Areas